Raampex Pharmaceuticals Private Limited
About Raampex Pharmaceuticals Private Limited
Data last updated:
Raampex Pharmaceuticals Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 04 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2017PTC099343. Its GSTIN is 24AAICR5590D1ZC (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhanwarlal Okaramji Choudhary and Sureshkumar Okaram Choudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 118 First Floor Shree Hari Complex Kansad Sachin, Surat, Gujarat, India – 394230.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.58 Lakh, a decline of 82% compared to the previous year. For the same year it recorded a net loss of ₹30,017 (net margin -19%) and EBITDA of -₹6,528 (EBITDA margin -4.1%). Revenue has declined at a compounded annual rate (CAGR) of 57% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Raampex Pharmaceuticals Private Limited's registered office is in Surat, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 118 First Floor Shree Hari Complex Kansad Sachin, Surat, Gujarat, India – 394230
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Raampex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Raampex Pharmaceuticals Private Limited
FY 2025 filings availableRaampex Pharmaceuticals Private Limited reported revenue of ₹1.58 Lakh (down 82% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 57% over three years, including a 82% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.58 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6,528 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹30,017 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.1% | ||||
| Net Profit Margin | -19% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raampex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Raampex Pharmaceuticals Private Limited
Raampex Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhanwarlal Okaramji Choudhary | Director | 04 Oct 2017 | 9 Years 0 Months | Current |
| Sureshkumar Okaram Choudhary | Director | 04 Oct 2017 | 9 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Raampex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raampex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raampex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICR5590D1ZC | Gujarat | Active | 15 Dec 2017 |
To see the full GST registrations and return filing status of Raampex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Raampex Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Mewada Mahendra ceased to be Director on 01 Feb 2019.
Frequently asked questions
Raampex Pharmaceuticals is an active private limited company based in Surat, Gujarat, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 04 October 2017 (9+ years old) and is registered under CIN U74999GJ2017PTC099343.
Raampex Pharmaceuticals has 2 current directors:
- Bhanwarlal Okaramji Choudhary - Director
- Sureshkumar Okaram Choudhary - Director
The latest financial statements of Raampex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Raampex Pharmaceuticals is 24AAICR5590D1ZC, registered in Gujarat.
The CIN (Corporate Identification Number) of Raampex Pharmaceuticals is U74999GJ2017PTC099343. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raampex Pharmaceuticals was incorporated on 04 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Mewada Mahendra ceased to be Director on 01 Feb 2019. Pravin Bhagwatilal Gandhi ceased to be Director on 01 Feb 2019. Bhanwarlal Okaramji Choudhary was appointed as Director on 04 Oct 2017. Raampex Pharmaceuticals has 4 board changes on record in total.
The registered office of Raampex Pharmaceuticals is at Shop No. 118 First Floor Shree Hari Complex Kansad Sachin, Surat, Gujarat, India – 394230.
Raampex Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Raampex Pharmaceuticals is compliant as of 09 September 2026. The company is actively filing with the Registrar of Companies.